Psorinum is a Oral Liquid in the Human Prescription Drug category. It is labeled and distributed by Energique, Inc.. The primary component is Scabies Lesion Lysate (human).
| Product ID | 44911-0097_0e27dae5-db51-4f1a-b12c-c3d8b3576a11 |
| NDC | 44911-0097 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Psorinum |
| Generic Name | Psorinum |
| Dosage Form | Liquid |
| Route of Administration | ORAL |
| Marketing Start Date | 2014-12-09 |
| Marketing End Date | 2025-09-22 |
| Marketing Category | UNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC |
| Labeler Name | Energique, Inc. |
| Substance Name | SCABIES LESION LYSATE (HUMAN) |
| Active Ingredient Strength | 7 [hp_X]/mL |
| NDC Exclude Flag | N |
| Marketing Start Date | 2014-12-09 |
| Marketing End Date | 2025-09-22 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | unapproved homeopathic |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2014-12-09 |
| Inactivation Date | 2020-01-31 |
| Ingredient | Strength |
|---|---|
| SCABIES LESION LYSATE (HUMAN) | 7 [hp_X]/mL |
| SPL SET ID: | fe712217-e56d-49f7-a791-0351f5e61896 |
| Manufacturer | |
| UNII |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0220-7604 | Psorinum | SCABIES LESION LYSATE (HUMAN) |
| 0220-7622 | Psorinum | SCABIES LESION LYSATE (HUMAN) |
| 0220-7623 | Psorinum | SCABIES LESION LYSATE (HUMAN) |
| 0220-7624 | Psorinum | SCABIES LESION LYSATE (HUMAN) |
| 0220-7625 | Psorinum | SCABIES LESION LYSATE (HUMAN) |
| 0220-7626 | Psorinum | SCABIES LESION LYSATE (HUMAN) |
| 44911-0097 | Psorinum | Psorinum |
| 62106-6903 | PSORINUM | Psorinum |
| 64117-407 | PSORINUM | SCABIES LESION LYSATE (HUMAN) |
| 69152-1204 | Psorinum 1M | Psorinum |
| 69152-1006 | Psorinum 200C | Psorinum |